If you are living with MS, what are others inheriting from you?

My MS advocacy journey and being a voice for change

For as long as I can remember, I’ve wanted to help others in any way I could. As early as middle school, I tried to identify a plausible and realistic career where I could fulfill this desire, and eventually landed on therapy as a possible career path. I wanted to…

Cannabinoids seen to ease MS spasticity, meta-analysis finds

Nabiximols and other cannabis-based preparations sometimes used with multiple sclerosis (MS) appear to work well for controlling spasticity, a common disease symptom that occurs when muscles stiffen or tighten, a meta-analysis of findings in published studies reported. Larger studies into cannabis-based treatments of spasticity for these patients…

Brain damage in MS children linked to lower socioeconomic status

Children with multiple sclerosis (MS) who come from poorer families or other disadvantageous circumstances tend to have more inflammation and irreversible brain tissue loss, a new study reports. “Our findings suggest that social disadvantage in childhood can have lasting effects on MS severity,” Kimberly A. O’Neill, MD, study coauthor…

Severe COVID-19 may double risk of MS: Swedish study

Hospitalization for severe COVID-19 is significantly associated with a twofold higher risk of developing multiple sclerosis (MS), according to a study involving nearly the entire population of Sweden. No increased risk of MS was found among those who tested positive for SARS-CoV-2, the virus that causes COVID-19, or received…

Roche to buy Poseida, building on CAR-T cell collaboration

Roche signed a definitive agreement to acquire Poseida Therapeutics, a deal that includes Poseida’s portfolio of CAR T-cell therapy candidates being developed for multiple sclerosis (MS) and other diseases. Poseida and Roche have been collaborating since 2022 on cell therapies for people with blood cancer. The companies…

High cholesterol linked to MS cognitive impairment in study

Higher cholesterol levels are associated with worse cognitive impairments in people with multiple sclerosis (MS), a study reported. The findings imply that medications or lifestyle changes that reduce cholesterol levels may be useful for addressing MS cognitive impairment, researchers said. The study, “Lipid measures are associated…

FDA clears upgraded software to aid MRI analysis in MS

The U.S. Food and Drug Administration (FDA) has cleared an extended version of Neurophet Aqua, an MRI analysis software that uses artificial intelligence (AI) to measure disease-related changes in brain scans. Earlier clearance enabled Neurophet‘s software to analyze brain atrophy using T1-weighed MRI scans in people with neurodegenerative conditions.

Therapy for immune tolerance in MS shows safety in early trial

LPX-TI641, Lapix Therapeutics‘ experimental oral therapy to restore immune system balance in people with multiple sclerosis (MS) and other autoimmune diseases, was found safe and well tolerated at all doses tested in healthy adults. That’s according to top-line data from a Phase 1 trial (NCT05853835), which…

Finding a way to treat the irritability that can come with MS

Too often, I’d find myself amid joyful moments with loved ones, struggling to keep irritability at bay. At those times, my mind would stagger between living in the happiness of the moment or an overwhelming sense of overstimulation, annoyance, and frustration. Most of the time, the irritability took over. When…

Embracing ambiguity while living in the gray

In recent months, while seeking to balance work, home life, family, and well-being, I’ve sought strategies to help me tackle perfectionism. On the health front, I’ve faced major struggles with my relapsing-remitting multiple sclerosis, secondary adrenal insufficiency, and avascular necrosis. However, to this day, my perfectionism is the most…

Nerve stimulation for bladder issues also can make sex more enjoyable

Percutaneous tibial nerve stimulation (PTNS), a nonsurgical treatment that delivers mild electrical impulses to a nerve in the ankle, significantly reduced bladder activity and improved sexual function for women with relapsing-remitting multiple sclerosis (RRMS), according to a clinical trial. While PTNS is designed to modulate neural mechanisms involved in…

AI tool aims to accelerate clinical trial patient recruitment

An artificial intelligence (AI)-based tool called Muse aims to accelerate drug development by optimizing clinical trial patient recruitment. The tool, designed as part of a collaboration among Formation Bio, OpenAI, and Sanofi, is designed to be implemented across a range of areas. Sanofi will first put it…

NYU scientist recognized for work on MS cognitive impairments

Cognitive rehabilitation scientist Yael Goverover, PhD, has been recognized with the title of Fellow of the American Congress of Rehabilitation Medicine (ACRM) for her contributions to research on multiple sclerosis (MS) and her efforts at advancing cognitive rehabilitation for people with the disease. Goverover’s work has focused on understanding…